Hello Bio launches small molecules for genome editing
Hello Bio announced today the launch of a range of small molecules that can be used for genome editing – including 4-Hydroxytamoxifen, azidothymidine and RS-1. These are valuable tools that enable scientists to make targeted modifications to the genome – modifications that include the deletion, insertion or other alterations of DNA sequences of cells or organisms.
Genome editing techniques include the Cre-LoxP / CreER and CRISPR/Cas9 systems. Small molecule compounds play a crucial role in these techniques and can enhance the overall efficiency and targeting precision of CRISPR/Cas-9-mediated genome editing for example.
We are proud to be at the forefront of science by manufacturing small molecules such as 4-Hydroxytamoxifen, azidothymidine and RS-1 - a range of small molecules that have such an impact on genome editing techniques. Genome editing is a cutting-edge area of research and holds great potential for applications across life science, biotechnology and medicine, so it's fantastic that we can make a contribution to this field.
Steve Roome PhD, Managing Director and Founder, Hello Bio
These small molecules for genome editing join a range of affordable and high quality tools for GPCR research,including the novel GRK2/3 inhibitor Cmpd101, that can be used to study GPCR desensitisation, and water-soluble Clozapine N-oxide , a novel DREADD ligand.
For more information, please contact
(0)117 3180 505
Hello Bio was founded by a team of experienced scientists and chemists who genuinely want to support life science research. Our aim is to offer a range of high quality life science tools at prices so low that as many researchers as possible will be able to afford them.
We offer a range of agonists, antagonists, inhibitors, activators, antibodies and fluorescent tools at up to half the price of other suppliers. The range includes:
We also offer a cost effective custom synthesis service for customers requiring specialist tools, or bulk quantities.